[go: up one dir, main page]

NO20081232L - Agarosebelagt, agarosesekretorisk cellekule, samt fremstilling og anvendelse derav - Google Patents

Agarosebelagt, agarosesekretorisk cellekule, samt fremstilling og anvendelse derav

Info

Publication number
NO20081232L
NO20081232L NO20081232A NO20081232A NO20081232L NO 20081232 L NO20081232 L NO 20081232L NO 20081232 A NO20081232 A NO 20081232A NO 20081232 A NO20081232 A NO 20081232A NO 20081232 L NO20081232 L NO 20081232L
Authority
NO
Norway
Prior art keywords
agarose
preparation
coated
well
secretory cell
Prior art date
Application number
NO20081232A
Other languages
English (en)
Other versions
NO341154B1 (no
Inventor
Lawrence Gazda
Barry Smith
Original Assignee
Rogosin Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rogosin Inst filed Critical Rogosin Inst
Publication of NO20081232L publication Critical patent/NO20081232L/no
Publication of NO341154B1 publication Critical patent/NO341154B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C12N5/0677—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
    • A61K2035/128—Immunoprotecting barriers, e.g. jackets, diffusion chambers capsules, e.g. microcapsules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/76—Agarose, agar-agar

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Dentistry (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Environmental Sciences (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Det beskrives fremstilling og anvendelse av kulestrukturer inneholdende sekretoriske celler, som er belagt med agarose. Kulene som fortrinnsvis er 4 mm-12 mm i diameter, og som fortrinnsvis inneholder øyceller, er fremstilt av en spesiell agarose, dvs. Seakem Gold agarose.
NO20081232A 2005-09-26 2008-03-10 Agarosebelagt, agarosesekretorisk cellekule, samt fremstilling og anvendelse derav NO341154B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72091705P 2005-09-26 2005-09-26
PCT/US2006/036125 WO2007038029A2 (en) 2005-09-26 2006-09-14 Secretory cell-containing macrobeads comprising seakem gold agarose, and uses thereof

Publications (2)

Publication Number Publication Date
NO20081232L true NO20081232L (no) 2008-04-23
NO341154B1 NO341154B1 (no) 2017-09-04

Family

ID=37900243

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20081232A NO341154B1 (no) 2005-09-26 2008-03-10 Agarosebelagt, agarosesekretorisk cellekule, samt fremstilling og anvendelse derav

Country Status (17)

Country Link
US (1) US8518394B2 (no)
EP (1) EP1928249B1 (no)
JP (1) JP4937265B2 (no)
KR (1) KR101110386B1 (no)
CN (1) CN101272690B (no)
AT (1) ATE547004T1 (no)
AU (1) AU2006295114B2 (no)
CA (1) CA2622529C (no)
DK (1) DK1928249T3 (no)
ES (1) ES2379008T3 (no)
IL (1) IL190028A (no)
NO (1) NO341154B1 (no)
NZ (1) NZ566621A (no)
PL (1) PL1928249T3 (no)
PT (1) PT1928249E (no)
RU (1) RU2417090C2 (no)
WO (1) WO2007038029A2 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE035164T2 (en) 2010-11-23 2018-05-02 The Rogosin Inst Inc A method for isolating a cancer cell resistant to a chemotherapeutic agent that exhibits stem cell properties
NZ624195A (en) 2012-01-31 2015-07-31 Rogosin Inst Improved method for manufacture of macrobeads
US9555007B2 (en) 2013-03-14 2017-01-31 Massachusetts Institute Of Technology Multi-layer hydrogel capsules for encapsulation of cells and cell aggregates

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983268A (en) * 1989-08-03 1991-01-08 Fmc Corporation High gel strength low electroendosmosis agarose
USRE38027E1 (en) * 1994-01-13 2003-03-11 The Rogosin Institute Preparation of agarose coated, solid agarose-collagen beads containing secretory cells
US20050147594A1 (en) * 2003-10-17 2005-07-07 Francois Leblond Semi-permeable microcapsule with covalently linked layers and method for producing same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5441878A (en) * 1987-12-08 1995-08-15 Thies Technology, Inc. Preparation of uniform droplets by using gas pressure to force liquid from a syringe and flowing gas to detach droplets
US5053332A (en) * 1989-07-24 1991-10-01 Cook Richard B Agarose beads, preferably incorporating biological materials
JPH07505922A (ja) * 1992-07-23 1995-06-29 エフ エム シー コーポレーション グルコマンナンスポンジ状マトリックス
US5651980A (en) * 1994-04-15 1997-07-29 Biohybrid Technologies, Inc. Methods of use of uncoated gel particles
US6303151B1 (en) 1996-04-03 2001-10-16 The Rogosin Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
US6224912B1 (en) 1996-04-03 2001-05-01 The Rogo Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
US5888497A (en) 1996-04-03 1999-03-30 The Rogosin Institute Agarose coated agarose beads containing cancer cells that produce material which suppresses cancer cell proliferation
US6997864B2 (en) 2003-11-03 2006-02-14 Otologics, Llc Method for obtaining diagnostic information relating to a patient having an implanted transducer
HRP20100472T1 (hr) 2004-11-17 2010-10-31 The Rogosin Institute Postupak procjene za određivanje pogodnosti pankreasa za izolaciju otočića

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983268A (en) * 1989-08-03 1991-01-08 Fmc Corporation High gel strength low electroendosmosis agarose
USRE38027E1 (en) * 1994-01-13 2003-03-11 The Rogosin Institute Preparation of agarose coated, solid agarose-collagen beads containing secretory cells
US20050147594A1 (en) * 2003-10-17 2005-07-07 Francois Leblond Semi-permeable microcapsule with covalently linked layers and method for producing same

Also Published As

Publication number Publication date
KR101110386B1 (ko) 2012-03-08
WO2007038029A3 (en) 2007-09-20
IL190028A0 (en) 2008-08-07
KR20080071122A (ko) 2008-08-01
CA2622529A1 (en) 2007-04-05
PL1928249T3 (pl) 2012-11-30
PT1928249E (pt) 2012-05-25
EP1928249B1 (en) 2012-02-29
WO2007038029A2 (en) 2007-04-05
EP1928249A2 (en) 2008-06-11
US20070071732A1 (en) 2007-03-29
AU2006295114A1 (en) 2007-04-05
CN101272690A (zh) 2008-09-24
JP2009509507A (ja) 2009-03-12
NZ566621A (en) 2010-07-30
JP4937265B2 (ja) 2012-05-23
IL190028A (en) 2014-12-31
RU2417090C2 (ru) 2011-04-27
AU2006295114B2 (en) 2010-01-28
HK1116995A1 (en) 2009-01-09
NO341154B1 (no) 2017-09-04
ATE547004T1 (de) 2012-03-15
ES2379008T3 (es) 2012-04-19
CA2622529C (en) 2014-02-18
RU2008114920A (ru) 2009-11-10
US8518394B2 (en) 2013-08-27
EP1928249A4 (en) 2010-04-07
DK1928249T3 (da) 2012-06-18
CN101272690B (zh) 2012-08-29

Similar Documents

Publication Publication Date Title
ATE535547T1 (de) Vernetzte antikörper
DK1520008T3 (da) Medium frit for dyreprotein til dyrkning af celler
IL199259A0 (en) Artificial receptors, building blocks, and methods
FI20041460L (fi) Parannetut, päällystetyt hioma-aineet
DE60333438D1 (de) Beschichtete gefässprothesen, verfahren zu deren herstellung und verwendung derselben
CR9478A (es) Anticuerpos dirigidos contra el peptido beta-amiloide y procedimientos que usan los mismos
DK1534277T3 (da) Acylerede, heteroaryl-kondenserede cycloalkenylaminer og anvendelse af disse som lægemidler
NO20070373L (no) Aerosol suspensjonsformulering inneholdende TG 227 EA eller TG 134 A som et drivmiddel
WO2004029219A3 (en) Cell-based rna interference and related methods and compositions
TR200102773T2 (tr) Alkoksisilan yapısal birimleri olan poliüretan eriyikleri
NO20065084L (no) Interferon-alfa polypeptider og konjugater
NO20034944D0 (no) Re-aktiverte T-celler for adoptiv immunoterapi
DK1974017T3 (da) Midler og fremgangsmåder til at påvirke stabiliteten af antistof producerende celler
DE60323405D1 (de) Zuverlässige gegenkontaktstruktur und techniken zu ihrer herstellung
DE50313510D1 (de) Zellkultureinsatz
CY1111769T1 (el) Παρασκευη κυτταρων
NO20081232L (no) Agarosebelagt, agarosesekretorisk cellekule, samt fremstilling og anvendelse derav
DK1499729T3 (da) Derivater af det NF-kappab-inducerende enzym, fremstilling og anvendelse deraf
DE60305990D1 (de) Dynamischer Dämpfer mit mehreren Freiheitsgraden
DK1511764T3 (da) Peptider og peptidomimetika, som er egnede til hæmning af aktiviteten af prostaglandin f2alfa-receptor
DE50310323D1 (de) Wässrige polyurethanzubereitungen
DE60324250D1 (de) Inhibitoren der alpha-l-beta-2-integrinvermittelten zelladhäsion
WO2005103229A3 (en) Transgenomic mitochondria, transmitochondrial cells and organisms, and methods of making and using
ATE395092T1 (de) Zementierbare endoprothesen
WO2006091775A3 (en) Tropoelastin for promoting endothelial cell adhesion or migration

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: THE ROGOSIN INSTITUTE, US

MM1K Lapsed by not paying the annual fees